tm
Seeing Is Believing
tm
Seeing Is Believing
Rain Therapeutics's activity chart (see below) currently has 37 price targets and 20 ratings on display.
Analysts average stock forecasts to be materialized ratio is 15.19% with an average time for these price targets to be met of 247.33 days.
Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 18-Sep-2023.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
$1
$-0.74 (-42.53%)
$24
2 years 9 months 26 days ago
(18-Sep-2023)
1/5 (20%)
$1 (0.00%)
472
Buy Since 18-May-2021
$1
$-0.74 (-42.53%)
$17
3 years 1 months 9 days ago
(05-Jun-2023)
1/6 (16.67%)
$1 (0.00%)
577
Hold Since 02-Jun-2023
3 years 1 months 12 days ago
(02-Jun-2023)
0/2 (0%)
$19 (0.00%)
Buy Since 22-May-2023
$1.2
$-0.54 (-31.03%)
$2
3 years 1 months 14 days ago
(30-May-2023)
2/3 (66.67%)
$1.2 (0.00%)
587
Hold
3 years 1 months 21 days ago
(23-May-2023)
0/1 (0%)
$9.77 (186.81%)
What is RAIN (Rain Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on RAIN (Rain Therapeutics) with a proven track record?
Which analyst has the current lower performing score on RAIN (Rain Therapeutics) with a proven track record?
Which analyst has the most public recommendations on RAIN (Rain Therapeutics)?
Which analyst is the currently most bullish on RAIN (Rain Therapeutics)?
Which analyst is the currently most reserved on RAIN (Rain Therapeutics)?
